RENAISSANCE TECHNOLOGIES LLC

Position in ARCT — Arcturus Therapeutics Holdings Inc.

CIK 1037389 NEW YORK, NY

Position in ARCT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$143,808

-$1,232,668 QoQ

Shares Held

21,400

-88.0% QoQ

Ownership

0.075%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#66

of 133 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. ARCT ranks #265 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$143,808	21,400	-88.0%	Shares	Sole	2026-08-13
2026-03-31	$1,376,476	178,300	+48.7%	Shares	Sole	2026-05-14
2025-12-31	$735,017	119,905	+1075.3%	Shares	Sole	2026-02-12
2023-12-31	$321,669	10,202	-94.3%	Shares	Sole	2024-02-13
2023-09-30	$4,591,335	179,700	-32.4%	Shares	Sole	2023-11-14
2023-06-30	$7,620,276	265,700	+895.6%	Shares	Sole	2023-08-11
2021-12-31	$987,685	26,687	-9.5%	Shares	Sole	2022-02-11
2021-06-30	$998,280	29,500	-79.3%	Shares	Sole	2021-08-13
2021-03-31	$5,897,640	142,800	—	Shares	Sole	2021-05-13
No filing history on record for this holder in this stock.